LiteVax

Akkersestraat 50

4061Bj Ophemert

NL

LiteVax

Foundation date

24/05/2012

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.

Upcoming events

Latest news

  • Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

    1 day ago

  • Celyad announces management change

    Friday December 1st 2023

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023